Temperature spike may exacerbate existing heart disease among men Dr. Kamal Kant Kohli25 March 2022 9:45 AM ISTAccording to a study presented at the American College of Cardiology's 71st Annual Scientific Session, extreme heat accounted for about 600-700...
Sacubitril/ Valsartan wasn't effective in controlling heart attack comparing to ramipril: PARADISE MI Trial MD Editorial Team23 Feb 2022 9:00 AM ISTMyocardial infarction, commonly called a heart attack is an extremely dangerous condition caused by a lack of blood flow to your heart muscle. The...
Rivaroxaban to prevent clinical outcomes in covid 19 patients: MICHELLE TRIAL MD Editorial Team19 Feb 2022 9:00 AM ISTCovid-19 also known SARS Cov-2 is popularly known to cause more fatal events where severe respiratory problems and multi organ failure in the infected...
Routine invasive therapy does not reduce major ischemic events: ISCHEMIA Trial MD Editorial Team16 Feb 2022 9:00 AM ISTIschemia is a serious concern as some part of the body, vital organs such as heart or brain, isn't getting enough blood. Approximately 1.5 million...
Vital trial: Vitamin D doesn't reduce risk of heart disease and stroke Dr. Nandita Mohan14 Feb 2022 7:00 PM ISTVitamin- D is an important metabolic hormone for maintaining a health and its benefits have been reported in many studies. Recent reports say Low...
Dapagliflozin a new approach in the treating patients with heart failure: DAPA – HF Trial MD Editorial Team14 Feb 2022 9:00 AM ISTCardiac health is very important as its one of the vital organs. Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an...
PREDIMED trial: olive oil improves heart health Dr. Nandita Mohan12 Feb 2022 10:59 AM ISTOlive oil is popularly consumed in most part of the world. The pillar ingredient of Mediterranean diet, consumption has drastically increased in...
Diabetic nephropathy effectively treated by Dapagliflozin: DAPA-CKD Trial MD Editorial Team12 Feb 2022 9:00 AM ISTDiabetes is a chronic disease that is the leading cause of kidney failure, accounting for 44% percent of new cases. Diabetic nephropathy is a serious...
ISCHEMIA Trial: Routine invasive therapy does not reduce MACE Dr. Nandita Mohan11 Feb 2022 7:11 PM IST The ISCHEMIA trial fails at proving that routine invasive therapy was associated with a reduction in major adverse ischemic events compared with...
LIFE Trial: sacubitril/valsartan combination not effective to treat HF Dr. Nandita Mohan11 Feb 2022 7:01 PM ISTThe LIFE trial highlights that combination sacubitril/valsartan did not reduce N-terminal pro b-type natriuretic peptide (NT-proBNP) or clinical...
PARADISE MI Trial: sacubitril/valsartan effective for heart attack Dr. Nandita Mohan11 Feb 2022 6:33 PM ISTThe PARADISE -MI trial assesed the efficacy and safety of sacubitril/valsartan compared with ramipril in a contemporary acute myocardial...
Dual Antiplatelet therapy much efficient in treating Cardiovascular death: MASTER DAPT Trial MD Editorial Team10 Feb 2022 9:00 AM ISTCardiac death is greater burden on global health. Fatal heart diseases involve formation of clots in major blood vessels, antiplatelet medicines can...
